Challenging for high quality AAV preps?  
Adeno-associated virus (AAV) is currently used as a safety viral vector in research and
gene therapy. However, it is difficult to prepare a high purity solution of the virus regardless
how much wanted.

C&M Biolabs has spent several years in addressing the difficulties and recently developed
out a new technology for AAV purification, enabling researchers to make any AAV solutions
in high quality easily and efficiently.

The new technology for AAV purification provides an ideal procedure for preparation
of high purity AAV, either in house in lab settings or in viral manufacturing in gene therapy.   
An ideal technology for AAV purification
The New Technology for AAV Purification
Main features:
 
A simple procedure saving time
 
Any volume of preps as needed
 
Great purity of viral solution
 
High recovery of viral particles
 
No cytotoxic compound involved
Application of the New Technology
Resolve issues in AAV purification
C&M Biolabs attempts to apply the new technology to gene therapy to resolve issues in AAV
manufacturing. It is, therefore, aimed to develop the technology-based bioprocess to
manufacture recombinant AAV for clinic use. Research use of the technology is intended to
license out for region-specific distributors. Click the buttons below for more information.
C&M Biolabs
San Francisco Bay Area
The company
Need help
Availability
© 2011-2020 C&M Biolabs. All rights reserved.
2600 Hilltop Drive, B-C147
Richmond, CA 94547

info@cmbiolabs.com
(510) 691-7166
Headquarter
We open for
  Products, Services and Collaboration